Physician profile
Colby Vossler
NPI 1730646035
$2,009.87
in general payments reported to CMS, 2019-2025
29 companies · $336 in 2025
The $336 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $374 · 2022: $534 · 2023: $407 · 2024: $359 · 2025: $336.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,102.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,101.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $202.84 | 2022-2025 | Jardiance |
| Abbvie INC. | $160.21 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $146.44 | 2021-2024 | Farxiga |
| Medtronic, INC. | $112.51 | 2022-2023 | Linq II |
| Philips North America LLC | $107.60 | 2022-2025 | Dose Professional Services, (Ck4) Mcot, Extended Holter |
| Janssen Pharmaceuticals, INC | $102.07 | 2021-2024 | Xarelto |
| Heartflow, INC. | $99.08 | 2024 | |
| Novo Nordisk INC | $88.58 | 2023-2025 | Ozempic, Rybelsus, Wegovy |
| Novartis Pharmaceuticals Corporation | $81.66 | 2024-2025 | |
| Pfizer INC. | $79.00 | 2022-2025 | |
| Siemens Medical Solutions USA, INC. | $76.81 | 2023-2024 | Atellica Im 1300 Analyzer, Somatom X.Cite |
| Boston Scientific Corporation | $73.67 | 2022-2025 | Watchman, Watchman Access System |
| Bridgebio Pharma, INC. | $64.51 | 2025 | Attruby |
| Amarin Pharma, INC. | $62.14 | 2021 | |
| Amgen INC. | $61.01 | 2021-2022 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Impulse Dynamics (USA) INC. | $59.53 | 2023 | Optimizer |
| Biohaven Pharmaceuticals, INC. | $54.69 | 2021 | |
| Nestle Healthcare Nutrition INC. | $53.56 | 2022 | |
| Daiichi Sankyo INC. | $44.77 | 2023-2024 | Injectafer |
| Ani Pharmaceuticals, INC. | $41.13 | 2025 | Purified Cortrophin Gel |
| Alnylam Pharmaceuticals INC. | $38.42 | 2022-2023 | Amvuttra |
| Bayer Healthcare Pharmaceuticals INC. | $36.49 | 2024-2025 | |
| Biohaven Pharmaceutical Holding Company LTD. | $32.45 | 2022 | |
| Merck Sharp & Dohme LLC | $31.31 | 2023 | Verquvo |
| Lilly USA, LLC | $25.14 | 2021 | |
| Becton, Dickinson and Company | $23.32 | 2025 | |
| Kiniksa Pharmaceuticals, LTD. | $19.93 | 2023 | Arcalyst |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $15.92 | 2023 | Lifevest |
| Glaxosmithkline, LLC. | $15.08 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Colby Vossler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.